lobbying_activities: 1345966

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1345966	cebf413a-c817-4673-bd7b-e1f1628fbd02	Q4	WALGREEN COMPANY	309071	WALGREEN COMPANY	2012	fourth_quarter	MMM	S. 274 - the "Medication Therapy Management Empowerment Act of 2011," all provisions regarding amending the Medicare Modernization Act to expand the eligibility of all targeted beneficiaries for access to Medication Therapy Management (MTM) in Medicare Part D. H.R. 891 - the "Medication Therapy Management (MTM) Benefits Act of 2011," all provisions related to the requirement of MTM services to include person-to-person targeted medication reviews by a licensed pharmacist offered at least every quarter and expand eligibility of all target beneficiaries for access to MTM. Issues relating to Medicares Competitive Bidding program that includes mail order/retail-provided diabetic testing supplies with regards to reimbursements provided to retail pharmacies. No specific legislation.	HOUSE OF REPRESENTATIVES,SENATE		790000	0	0	2013-01-18T16:17:57.993000-05:00